Viewing Study NCT00383851


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-01-29 @ 2:56 PM
Study NCT ID: NCT00383851
Status: UNKNOWN
Last Update Posted: 2007-12-06
First Post: 2006-10-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma
Sponsor: Attenuon
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ATN-224 View
None Temozolomide View
None Combination View
None Sequential View
None Anti-angiogenic View
None Copper View